Delivery Order SPE2DB22D3501-SPE2DB26FTH20
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 22, 2025, for the supply of Copaxone 40 mg/ml syringes. This firm fixed price delivery order, valued at $2,163.92, represents a competitive award with no set-aside designation and is scheduled for completion by September 23, 2025. The contract will be performed at AmerisourceBergen's Conshohocken facility. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,065.20 to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes. This non-competitive, firm fixed-price delivery order was issued on October 30, 2025, with an ultimate completion date of October 31, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Copaxone 40 mg/mL syringes with a firm fixed price ceiling value of $2,645.73. This is a non-set-aside competitive award, reflecting AmerisourceBergen's qualification to compete openly for federal medical procurement needs. The delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,522.65 to AmerisourceBergen Drug Corp for the supply of Copaxone 20 mg/mL syringes. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 22, 2025. This delivery order is a child contract issued under...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at one thousand fifty-five dollars and fifty-two cents ($1,055.52) by the Defense Logistics Agency Troop Support Medical to provide forty milligram per milliliter syringes of Copaxone, used to treat multiple sclerosis. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a one day period from September 11 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, valued at $1,971.90 with a firm fixed price structure. The order was competitively awarded without set-aside provisions and is scheduled for completion by September 11, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/mL syringes under a firm fixed-price contract with a ceiling value of $1,128.54. This non-set-aside award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a direct delivery order fulfillment. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp, a major...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at approximately $2,795.45 by the Defense Logistics Agency Troop Support Medical (DLA) to supply Copaxone 40 mg/ml syringes. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 7-10, 2023. No set aside designation or subcontracting details were provided. DLA manages the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,583.28 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to supply 4563094173 COPAXONE 40 MG/ML SYRINGEML. As the prime contractor, Amerisourcebergen Drug Corp will deliver the multiple sclerosis medication from its headquarters in Conshohocken, Pennsylvania by December 14, 2023. No set-aside designation was used for this order placed against an existing...
- The Defense Logistics Agency awarded a $5,051.58 delivery order to AmerisourceBergen Drug Corp for COPAXONE 20 mg/ml syringes, with an ultimate completion date of September 15, 2025. This is a firm fixed price, non-set-aside contract issued on September 12, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTH20Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Copaxone 40 mg/ml syringes valued at $1,712.99. The award was made on October 29, 2025, with an ultimate completion date of October 30, 2025, under a Firm Fixed Price contract type with no set-aside designation. This delivery order represents a competitive procurement action and falls under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical, a substantial $999,999,999.00 vehicle running through December 2026 that serves as a comprehensive pharmaceutical support mechanism for military healthcare programs. The delivery order reflects AmerisourceBergen's role as a critical vendor within the federal medical supply chain, supporting the Defense Health Agency and other government healthcare systems. Copaxone is a disease-modifying therapy commonly used in the treatment of multiple sclerosis, and this procurement supports the pharmaceutical needs of military personnel and veterans. The order will be performed at the company's corporate office location in Conshohocken, Pennsylvania, consistent with the organization's established role as a primary pharmaceutical distributor for the Department of Defense's medical logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/29/25 |